Health Condition 1: M791- Myalgia
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1 Patients diagnosed with myofascial pain as per DC TMD Ib with active trigger points involving masseter muscle 2 Patients consent for participation in the study
Exclusion criteria
Exclusion criteria: 1 Patients with a phobia to needles 2 Patients who have undergone previous treatment for myofascial pain 3 Patients with active infection at the site of injection or overlying skin 4 Patients with a history of trauma to the maxillofacial region in past 6 months 5 Patients with other types of orofacial pain and musculoskeletal disorders. 6 Patients with parafunctional habits 7 Healing disorders or systemic diseases where healing is compromised 8 Patients on anticoagulant therapy 9 Bleeding and clotting disorders 10 Patients with epilepsy seizures 11 Pregnancy and lactation 12 Patients addicted to alcohol drugs 13 BDI in moderate and severe category
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| NRS for assessment of pain score MO, PM, RTLEM, and LTLEM in mm for evaluation of functional movements. Timepoint: Baseline, 1 week, 2 weeks, 3 weeks, 4 weeks and 3 months. | — |
Secondary
| Measure | Time frame |
|---|---|
| To assess patient satisfaction (Likert scale) To evaluate the need for alternative treatment in both groups (as frequency) To evaluate the side effects of injectable platelet rich plasma, photobiomodulation if any (as frequency) Timepoint: Baseline, 1 week, 2 weeks, 3 weeks, 4 weeks and 3 months. | — |
Countries
India
Contacts
PGIDS, Rohtak